Article Text

Download PDFPDF
Republished research: Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial
  1. Kevin J Bell1,
  2. Mark L Fulcher2,
  3. David S Rowlands3,
  4. Ngaire Kerse2
  1. 1Sydney Sports Medicine Centre, Sydney Olympic Park, NSW 2127, Australia
  2. 2Department of General Practice and Primary Health Care, School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
  3. 3School of Sport and Exercise, Massey University, Wellington, New Zealand
  1. Correspondence to: K J Bell, Sydney Sports Medicine Centre, PO Box 3275, Rhodes, NSW 2138, Australia


Study question Do peritendinous autologous blood injections improve pain and function in people with mid-portion Achilles tendinopathy?

Summary answer The administration of two unguided peritendinous autologous blood injections one month apart, in addition to a standardised eccentric training programme, provides no additional benefit in the treatment of mid-portion Achilles tendinopathy.

What is known and what this paper adds Several studies have suggested that injection of autologous blood can help in the treatment of various tendinopathies. There is a lack of high quality evidence showing relevant benefit for autologous blood injections, particularly in the management of mid-portion Achilles tendinopathy. We found no additional reduction in pain or improvement in function when these injections were combined with an eccentric calf training programme.

View Full Text

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.